e-therapeutics is integrating computational power and biology to accelerate the discovery of life-transforming RNAi medicines.

We have developed and validated a powerful computational approach to drug discovery, leveraging our industry-leading expertise in network biology to fully capture and interrogate human disease complexity. Our multi-disciplinary team builds computational models of biological functions to transform the search for new medicines, interventions, mechanisms and genetic support.

Our biology-led in silico laboratory enables rapid hypothesis generation, phenotypic screening and the identification and prioritisation of novel therapeutic targets. We have developed a proprietary GalNAc-siRNA platform technology for highly specific silencing of gene expression in the liver. Harnessing internal target gene discoveries, we are building an in-house pipeline of next-generation RNAi-based medicines.

Registered office:

Unit 4B, Level 4, 4 Kingdom Street, London W2 6PY 

For all enquiries, please contact: 

Email: contact@etherapeutics.co.uk
Tel: +44 (0) 20 4551 8888

e-therapeutics is listed on the Alternative Investment Market of the London Stock Exchange (“AIM”), with ticker symbol ETX. e-therapeutics is also traded on the OTCQX Best Market (OTCQX) in the United States (US), under the ticker symbol ETXPF.

Number of AIM securities in issue: 514,614,982 ordinary shares of 0.1p
Percentage of AIM securities not in public hands: 38.1%

Listing: AIM

There are no restrictions on the transfer of the Company’s ordinary shares.
Last updated: 11 July 2022.

Significant shareholdings 

  • Richard Griffiths and controlled undertakings – 143,539,105 (27.89%)
  • Robert Quested - 68,320,000 (13.28%)
  • Ali Mortazavi – 50,941,666 (9.90%)
  • M&G – 34,375,000 (6.68%)
  • Trillian Ltd – 30,454,847 (5.92%)
  • David Richardson - 24,779,030 (4.82%)
  • Lombard Odier Asset Management – 18,082,221 (3.51%)

Last updated: 11 July 2022.

Nominated advisor and broker
SP Angel Corporate Finance LLP
Prince Frederick House
35–39 Maddox Street
London
W1S 2PP
020 3470 0470
www.spangel.co.uk

Bankers
Bank of Scotland
PO Box No 10
38 St. Andrew Square
Edinburgh
EH2 2AD
Tel: +44 (0) 131 465 3900
www.bankofscotland.co.uk

Registrars
Neville Registrars Limited
Neville House
18 Laurel Lane
Halesowen
West Midlands
B63 3DA
Tel: +44 (0) 121 585 1131
Fax: +44 (0) 121 585 1132
www.nevilleregistrars.co.uk

Auditors
Grant Thornton UK LLP
30 Finsbury Square
London
EC2A 1AG
www.grantthornton.co.uk

Solicitors
Stephenson Harwood LLP
1 Finsbury Circus
London
EC2M 7SH
Tel: +44 (0) 20 7329 4422
www.shlegal.com

Upcoming meetings and events throughout the financial year.

Preliminary Results 04 May 2022
AGM 19 July 2022